From: Implementation of individualised polygenic risk score analysis: a test case of a family of four
Phenotype Group | Phenotype (PheWAS Code) | Source (ID/PheWAS) | GWAS Consortium | # SNPs | Missing SNPs | % Missing SNPs | Validation | Status | Reason for filtering out |
---|---|---|---|---|---|---|---|---|---|
Autoimmune | Inflammatory Bowel Disease | PGS Catalog (PGS000017) | [3] | 69,07,112 | – |  | UKB | Selected |  |
Lupus | PGS Catalog (PGS000328) | [25] | 57 | 32 | 56.14% | UKB | Unselected | Missing SNPs > 5% | |
Cancer | Breast Cancer | PGS Catalog (PGS000015) | [3] | 5,218 | – |  | UKB | Selected |  |
Prostate Cancer | PGS Catalog (PGS000333) | [22] | 66,06,785 | 832 | 0.01% | FINRISK | Selected | Â | |
Glaucoma | PGS Catalog (PGS000137) | [28] | 2,673 | 16 | 0.60% | UKB | Selected | Â | |
Testicular Cancer | Cancer-PRSweb (187.2) | 43 | – |  | UKB | Selected |  | ||
Chronic Lymph Leukaemia | Cancer-PRSweb (204.12) | 27 | – |  | UKB | Selected |  | ||
Thyroid cancer | Cancer-PRSweb (193) | 5 | – |  | UKB | Selected |  | ||
Glioma | Cancer-PRSweb (191.1) | 19 | – |  | UKB | Selected |  | ||
Melanoma | Cancer-PRSweb (172.1) | 27 | 1 | 3.70% | UKB | Selected | Â | ||
Colorectal Cancer | Cancer-PRSweb (153) | [61] | 87 | 1 | 1.15% | UKB | Selected | Â | |
Basal Cell Carcinoma | Cancer-PRSweb (172.21) | 24 | 1 | 4.17% | UKB | Selected | Â | ||
Cardiovascular | Atrial Fibrillation | PGS Catalog (PGS000016) | [3] | 67,30,541 | – |  | UKB | Selected |  |
Coronary Artery Disease | PGS Catalog (PGS000013) | [3] | 66,30,150 | – |  | UKB | Selected |  | |
Ischaemic Stroke | PGS Catalog (PGS000039) | [109] | 32,25,583 | 11,103 | 0.34% | UKB | Selected | Â | |
Metabolic | Type 2 Diabetes | PGS Catalog (PGS000014) | [3] | 69,17,436 | – |  | UKB | Selected |  |
Testosterone Levels (female) | PGS Catalog (PGS000323) | [112] | 7,168 | – |  | UKB | Unselected | Missing SNPs > 5% | |
Testosterone Levels (male) | PGS Catalog (PGS000322) | [112] | 8,235 | – |  | UKB | Unselected | Missing SNPs > 5% |